🇺🇸 FDA
Pipeline program

Study Product A (High-dose 2X)

22-RB-07-AY-001

Unknown other active

Quick answer

Study Product A (High-dose 2X) for Hyperuricemia is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Hyperuricemia
Phase
Unknown
Modality
other
Status
active

Clinical trials